[go: up one dir, main page]

NO881300D0 - Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater. - Google Patents

Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater.

Info

Publication number
NO881300D0
NO881300D0 NO881300A NO881300A NO881300D0 NO 881300 D0 NO881300 D0 NO 881300D0 NO 881300 A NO881300 A NO 881300A NO 881300 A NO881300 A NO 881300A NO 881300 D0 NO881300 D0 NO 881300D0
Authority
NO
Norway
Prior art keywords
alkyl
hydrogen
alkoxy
alkylthio
procedure
Prior art date
Application number
NO881300A
Other languages
English (en)
Other versions
NO881300L (no
Inventor
Leslie Richard Hughes
Original Assignee
Ici Plc
101 Newington Causeway
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Plc, 101 Newington Causeway filed Critical Ici Plc
Publication of NO881300D0 publication Critical patent/NO881300D0/no
Publication of NO881300L publication Critical patent/NO881300L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
    • C07D239/96—Two oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88—Oxygen atoms
    • C07D239/90—Oxygen atoms with acyclic radicals attached in position 2 or 3

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO881300A 1987-03-25 1988-03-24 Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater. NO881300L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB878707053A GB8707053D0 (en) 1987-03-25 1987-03-25 Anti-tumour agents

Publications (2)

Publication Number Publication Date
NO881300D0 true NO881300D0 (no) 1988-03-24
NO881300L NO881300L (no) 1988-09-26

Family

ID=10614570

Family Applications (1)

Application Number Title Priority Date Filing Date
NO881300A NO881300L (no) 1987-03-25 1988-03-24 Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater.

Country Status (17)

Country Link
US (1) US4981856A (no)
EP (1) EP0284338B1 (no)
JP (1) JP2577036B2 (no)
AT (1) ATE98956T1 (no)
AU (1) AU600105B2 (no)
CA (1) CA1301756C (no)
DE (1) DE3886435T2 (no)
DK (1) DK167013B1 (no)
ES (1) ES2061641T3 (no)
FI (1) FI881340A7 (no)
GB (2) GB8707053D0 (no)
GR (1) GR3010208T3 (no)
IL (1) IL85696A (no)
NO (1) NO881300L (no)
NZ (1) NZ224010A (no)
PT (1) PT87074B (no)
ZA (1) ZA881885B (no)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8727737D0 (en) * 1987-11-26 1987-12-31 Ici Plc Antitumour agents
GB8809978D0 (en) * 1988-04-27 1988-06-02 Ici Plc Anti-tumour agents
EP0365763A1 (en) * 1988-09-30 1990-05-02 Agouron Pharmaceuticals, Inc. Antiproliferative cyclic compounds
GB8829296D0 (en) * 1988-12-15 1989-01-25 Ici Plc Anti-tumour compounds
US5252573A (en) * 1988-12-15 1993-10-12 Imperial Chemical Industries Plc Anti-tumor agents
US5160727A (en) * 1990-02-13 1992-11-03 Warner-Lambert Company Tumor cell sensitization method using quinazolinedione derivatives
ZA913730B (en) * 1990-05-30 1992-02-26 Ici Plc Anti-tumor compounds
GB9013615D0 (en) * 1990-06-19 1990-08-08 Wellcome Found Pharmaceutical compounds
GB9105771D0 (en) * 1991-03-19 1991-05-01 Cancer Res Inst Royal Anti-cancer compounds
US5145854A (en) * 1991-11-27 1992-09-08 Nair Madhavan G 1-formyl-5,8,10-trideazafolates
GB9205320D0 (en) * 1992-03-11 1992-04-22 Ici Plc Anti-tumour compounds
GB9205907D0 (en) * 1992-03-18 1992-04-29 Cancer Res Inst Royal Anti-cancer compounds
US5430148A (en) * 1992-03-31 1995-07-04 Agouron Pharmaceuticals, Inc. Antiproliferative quinazolines
GB9223352D0 (en) * 1992-11-06 1992-12-23 Ici Plc Tricyclic compounds
DE4421884A1 (de) 1994-06-23 1996-01-04 Hoechst Ag Verfahren zur Herstellung von Hydroxycarbonsäureaniliden
DE4427837A1 (de) 1994-08-05 1996-02-08 Hoechst Ag Verfahren zur Herstellung von O-Acylglykolsäureaniliden
DE19504225A1 (de) 1995-02-09 1996-08-14 Hoechst Ag Verfahren zur Herstellung von O-Acyloxycarbonsäureaniliden
US5739330A (en) * 1996-02-05 1998-04-14 Hoechst Celanese Corporation Process for preparing quinazolones
GB9904275D0 (en) 1999-02-24 1999-04-21 Cancer Res Campaign Tech Anti-cancer compounds
US7230000B1 (en) 1999-10-27 2007-06-12 Cytokinetics, Incorporated Methods and compositions utilizing quinazolinones
US6545004B1 (en) 1999-10-27 2003-04-08 Cytokinetics, Inc. Methods and compositions utilizing quinazolinones
US6753428B2 (en) * 2001-11-20 2004-06-22 Cytokinetics, Inc. Process for the racemization of chiral quinazolinones
US7087418B2 (en) 2001-12-19 2006-08-08 Bristol-Myers Squibb Company Pichia pastoris formate dehydrogenase and uses therefor
JP2005529076A (ja) * 2002-02-15 2005-09-29 サイトキネティクス・インコーポレーテッド キナゾリノンの合成
WO2003097053A1 (en) 2002-05-09 2003-11-27 Cytokinetics, Inc. Compounds, compositions, and methods
US7166595B2 (en) * 2002-05-09 2007-01-23 Cytokinetics, Inc. Compounds, methods and compositions
US7038048B2 (en) 2002-05-23 2006-05-02 Cytokinetics, Inc. 3H-pyridopyrimidin-4-one compounds, compositions, and methods of their use
CA2489367A1 (en) * 2002-06-14 2003-12-24 Cytokinetics, Inc. Compounds, compositions, and methods
WO2004009036A2 (en) * 2002-07-23 2004-01-29 Cytokinetics, Inc. Compounds compositions and methods
WO2004018058A2 (en) * 2002-08-21 2004-03-04 Cytokinetics, Inc. Compounds, compositions, and methods
JP2006501306A (ja) * 2002-09-30 2006-01-12 サイトキネティクス・インコーポレーテッド 化合物、組成物および方法
GB0317631D0 (en) * 2003-07-28 2003-08-27 Btg Int Ltd Synthetic method
WO2005041888A2 (en) * 2003-11-03 2005-05-12 Cytokinetics, Inc. Pyrimidin-4-one compounds, compositions and methods
EP1680420A4 (en) * 2003-11-07 2008-09-24 Cytokinetics Inc COMPOUNDS, COMPOSITIONS AND METHODS
EP1692112A4 (en) * 2003-12-08 2008-09-24 Cytokinetics Inc COMPOUNDS, COMPOSITIONS, AND METHODS
AU2008268613A1 (en) * 2007-06-22 2008-12-31 Arqule, Inc. Quinazolinone compounds and methods of use thereof
US8940742B2 (en) 2012-04-10 2015-01-27 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
WO2015051241A1 (en) 2013-10-04 2015-04-09 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
HUE057734T2 (hu) 2013-10-04 2022-06-28 Infinity Pharmaceuticals Inc Heterociklusos vegyületek és alkalmazásuk
CN113616656B (zh) 2014-03-19 2023-02-17 无限药品股份有限公司 用于治疗PI3K-γ介导的障碍的杂环化合物
WO2016054491A1 (en) 2014-10-03 2016-04-07 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof
EP3350183B1 (en) 2015-09-14 2025-04-02 Twelve Therapeutics, Inc. Solid forms of isoquinolinone derivatives, process of making, compositions comprising, and methods of using the same
WO2017161116A1 (en) 2016-03-17 2017-09-21 Infinity Pharmaceuticals, Inc. Isotopologues of isoquinolinone and quinazolinone compounds and uses thereof as pi3k kinase inhibitors
WO2017214269A1 (en) 2016-06-08 2017-12-14 Infinity Pharmaceuticals, Inc. Heterocyclic compounds and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0031237B1 (en) * 1979-12-19 1984-10-17 National Research Development Corporation Quinazoline derivatives, processes for their preparation, compositions containing them and their use as anti-cancer agents
GB8513754D0 (en) * 1985-05-31 1985-07-03 Jones T R Anti-cancer quinazoline derivatives
GB8607683D0 (en) * 1986-03-27 1986-04-30 Ici Plc Anti-tumor agents

Also Published As

Publication number Publication date
ES2061641T3 (es) 1994-12-16
GB2202847B (en) 1990-06-06
JP2577036B2 (ja) 1997-01-29
EP0284338A3 (en) 1989-05-17
JPS63255270A (ja) 1988-10-21
IL85696A (en) 1993-05-13
DK167013B1 (da) 1993-08-16
FI881340A7 (fi) 1988-09-26
EP0284338B1 (en) 1993-12-22
GR3010208T3 (no) 1994-03-31
GB2202847A (en) 1988-10-05
PT87074A (pt) 1988-04-01
GB8707053D0 (en) 1987-04-29
DK168488A (da) 1988-09-26
NZ224010A (en) 1990-12-21
DE3886435D1 (de) 1994-02-03
NO881300L (no) 1988-09-26
PT87074B (pt) 1992-07-31
GB8805982D0 (en) 1988-04-13
DK168488D0 (da) 1988-03-25
AU1327988A (en) 1988-09-29
US4981856A (en) 1991-01-01
EP0284338A2 (en) 1988-09-28
AU600105B2 (en) 1990-08-02
CA1301756C (en) 1992-05-26
FI881340A0 (fi) 1988-03-21
ATE98956T1 (de) 1994-01-15
DE3886435T2 (de) 1994-04-14
ZA881885B (en) 1988-09-26

Similar Documents

Publication Publication Date Title
NO881300L (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater.
IE870699L (en) Quinazoline derivatives
DE3588100D1 (de) Carbamidsäureester-Derivate, Mittel und Herstellungsverfahren
EP0444659A3 (en) A pharmaceutical solution
NO301543B1 (no) 2-£4-(kinazolinylmetylamino)benzamido|-4-(tetrazolyl)smörsyrederivater med anti-tumor-aktivitet
FI885559A0 (fi) Anvaendning av d-cykloserin och dess prodrug som cognition oekande medel.
DK0490566T3 (da) Fremstilling og anvendelse af N-iodpropargyloxycarbonylaminosyreestere og derivater som antimikrobielle midler
ES8706321A1 (es) Procedimieno para preparar derivados de oximas con actividad fungicida
DK377687A (da) Triazol-fungicidpraeparater
ZA882374B (en) Biologically active compounds
ES8404370A1 (es) Procedimiento para preparar fosfatos de oximas aciclicos y heterociclicos con actividad insecticida, acaricida y nematocida.
ES8406489A1 (es) Procedimiento para la obtencion de derivados de pirano-pirazol
AU555944B2 (en) Phosphorus derivatives of carbamimidothioic esters